Pancreatic Cancer Research

ResearcherBC Cancer AgencyActive in the last 2 years

Sylvia S. W. Ng

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0009-0007-0103-3591; OpenAlex author ID A5108570979. Sources: OpenAlex.

Their work

Papers
7 (first author 0, last author 3)
Trials
0
Grants
0
Labs led
0
Collaborators
25
Papers, trials and grants by year

2013: 1 paper · 2014: none · 2015: 1 paper · 2016: 1 paper · 2017: none · 2018: none · 2019: none · 2020: none · 2021: none · 2022: 1 paper · 2023: none · 2024: 1 paper · 2025: none · 2026: 2 papers

Papers 7

  1. Stereotactic Body Radiation Therapy for Locally Advanced Pancreatic Adenocarcinoma: A Systematic Review and Meta-Analysis of Prospective Trials. Last author DOI 10.1016/j.prro.2026.04.015↗
  2. Adjuvant Chemoradiotherapy for Pancreatic Adenocarcinoma. Co-author DOI 10.1016/j.soc.2025.04.006↗
  3. Canadian National Pancreas Conference 2023: A Review of Multidisciplinary Engagement in Pancreatic Cancer Care. Co-author DOI 10.3390/curroncol31100461↗
  4. Inflammatory Cytokines and Radiotherapy in Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.3390/biomedicines10123215↗
  5. The differential effects of metronomic gemcitabine and antiangiogenic treatment in patient-derived xenografts of pancreatic cancer: treatment effects on metabo… Last author DOI 10.1007/s10456-016-9503-z↗
  6. The involvement of insulin-like growth factor 2 binding protein 3 (IMP3) in pancreatic cancer cell migration, invasion, and adhesion. Last author DOI 10.1186/s12885-015-1251-8↗
  7. The autophagy inhibitor verteporfin moderately enhances the antitumor activity of gemcitabine in a pancreatic ductal adenocarcinoma model. Co-author DOI 10.7150/jca.7030↗

Closest collaborators

The 25 strongest of 25 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Sheron Perera · 1 shared paper, 2026 · strength 0.50
  2. Natalie G. Coburn · 1 shared paper, 2026 · strength 0.50
  3. Laura Ann Dawson · 1 shared paper, 2022 · strength 0.33
  4. K. Liang Zeng · 1 shared paper, 2026 · strength 0.26
  5. Simon Shek-Man Lo · 1 shared paper, 2026 · strength 0.26
  6. Marta Scorsetti · 1 shared paper, 2026 · strength 0.26
  7. Matthias Gückenberger · 1 shared paper, 2026 · strength 0.26
  8. Ravi Ramjeesingh · 1 shared paper, 2024 · strength 0.16
  9. Stacey N. Lee · 1 shared paper, 2024 · strength 0.16
  10. Chloe Cyr · 1 shared paper, 2024 · strength 0.16
  11. Masoom A. Haider · 1 shared paper, 2024 · strength 0.16
  12. Boris Gala-López · 1 shared paper, 2024 · strength 0.16
  13. Riley J. Arseneau · 1 shared paper, 2024 · strength 0.16
  14. Keith John Roberts · 1 shared paper, 2024 · strength 0.16
  15. Sharlene Gill · 1 shared paper, 2024 · strength 0.16
  16. Christina Kim · 1 shared paper, 2024 · strength 0.16
  17. Jessica L. Nickerson · 1 shared paper, 2024 · strength 0.16
  18. Erica S. Tsang · 1 shared paper, 2024 · strength 0.16
  19. George Zogopoulos · 1 shared paper, 2024 · strength 0.16
  20. Donald T. T. Yapp · 2 shared papers, 2015–2016 · strength 0.11
  21. Clarissa C. Pasiliao · 1 shared paper, 2015 · strength 0.06
  22. David F. Schaeffer · 1 shared paper, 2015 · strength 0.06
  23. Andrzej K. Buczkowski · 1 shared paper, 2016 · strength 0.05
  24. Elizabeth Donohue · 1 shared paper, 2013 · strength 0.03
  25. Michel Roberge · 1 shared paper, 2013 · strength 0.03

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.